{
  "author": {
    "name": "Joshua Horn",
    "webUrl": "/author/profile/joshua-horn/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 1,
    "social": [],
    "articles": [
      {
        "uri": "/2019/06/27/fda-hearing-on-cannabis-products-cbd-takes-center-stage-414-157857/",
        "title": "CBD takes center stage at FDA hearing on cannabis products",
        "byline": "Joshua Horn and Ellis W. Martin",
        "kicker": "News",
        "prettyDate": "June 27, 2019",
        "timeToRead": "7 minute",
        "image": {
          "uri": "https://images.propertycasualty360.com/contrib/content/uploads/sites/414/2019/06/CBD-Oil-Article-201906271514.jpg",
          "width": "457",
          "height": "372"
        },
        "authors": [
          {
            "webUrl": "/author/profile/joshua-horn/",
            "name": "Joshua Horn"
          },
          {
            "webUrl": "/author/profile/ellis-w-martin/",
            "name": "Ellis W. Martin"
          }
        ],
        "kickerNode": [
          {
            "uri": "/news/",
            "sectionName": "News"
          }
        ],
        "summary": "The federal agency set a July 2 deadline for written responses to the issues raised in the hearing.",
        "body": null
      }
    ]
  }
}